CN Patent

CN113226322A — 作为bet抑制剂的杂环化合物

Assigned to Novelson Biological Co ltd · Expires 2021-08-06 · 5y expired

What this patent protects

提供了新型布罗莫结构域和额外末端结构域(BET)抑制剂和使用这些新型BET抑制剂治疗病症或疾病的治疗方法。

USPTO Abstract

提供了新型布罗莫结构域和额外末端结构域(BET)抑制剂和使用这些新型BET抑制剂治疗病症或疾病的治疗方法。

Drugs covered by this patent

trametinib-dimethyl-sulfoxide (TRAMETINIB DIMETHYL SULFOXIDE)

Patent Metadata

Patent number: CN113226322A
Jurisdiction: CN
Classification: —
Expires: 2021-08-06
Drug substance claim: No
Drug product claim: No
Assignee: Novelson Biological Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.